We are thankful for our customers and associates and continue remaining deeply dedicated to customer service and community involvement, and being a great place to work and shop
TRIUMPH-1 Phase 3 Trial Results (May 2026) On May 21, 2026, Eli Lilly announced topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial for retatrutide
Pabau's built-in claims management tools help practices catch missing secondary codes, flag sequencing errors before submission, and maintain consistent patient records across every post-surgical follow-up encounter
After reconstitution with bacteriostatic water, refrigerate (4 C)
Many professionals report feeling revitalized within minutes of completing a session
There is no doubt that the gut microbiome is extremely relevant to human health and disease status